The New Jersey Supreme Court has ordered consolidation of more than 350 suits over alleged side effects from breast cancer drug Taxotere.
The court designated all cases involving allegations of hair loss from Taxotere as multicounty litigation, and assigned the group to Superior Court Judge James Hyland in Middlesex County for centralized case management. Chief Justice Stuart Rabner approved the application on Aug. 17.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]